Extracellular Vesicle-Encapsulated miR-29b-3p Released From Bone Marrow-Derived Mesenchymal Stem Cells Underpins Osteogenic Differentiation

OBJECTIVE: Mesenchymal stem cells (MSCs) confer therapeutic benefits in various pathologies and cancers by releasing extracellular vesicles (EVs) loaded with bioactive compounds. Herein, we identified bone marrow MSC (BMSC)-derived EVs harboring microRNA (miR)-29b-3p to regulate osteogenic different...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xueliang, Wang, Wenji, Wang, Yongping, Zhao, Haiyan, Han, Xingwen, Zhao, Tong, Qu, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862561/
https://www.ncbi.nlm.nih.gov/pubmed/33553139
http://dx.doi.org/10.3389/fcell.2020.581545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862561/
https://www.ncbi.nlm.nih.gov/pubmed/33553139
http://dx.doi.org/10.3389/fcell.2020.581545

Ejemplares similares